Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Medical Microbiology

• Publication date

  2011-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1099/jmm.0.033167-0PMID 21680766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efflux-Mediated Drug Resistance in Bacteria

  2012cited by this paper
• Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.

  2010cited by this paper
• Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.

  2008cited by this paper
• Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

  2006cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard

  2006cited by this paper
• Piperine, a Phytochemical Potentiator of Ciprofloxacin against Staphylococcus aureus

  2006cited by this paper
• Can efflux inhibitors really counter resistance

  2006cited by this paper
• Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat.

  2006cited by this paper
• The role of nasal carriage in Staphylococcus aureus infections.

  2005cited by this paper
• Efflux-mediated multiresistance in Gram-negative bacteria.

  2004cited by this paper
• Novel Chromosomally Encoded Multidrug Efflux Transporter MdeA in Staphylococcus aureus

  2004influential reference
• Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers.

  2004cited by this paper
• Active efflux, a common mechanism for biocide and antibiotic resistance

  2002cited by this paper
• Active efflux, a common mechanism for biocide and antibiotic resistance.

  2002cited by this paper
• Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.

  2002cited by this paper
• INTRANASAL MUPIROCIN TO PREVENT POSTOPERATIVE STAPHYLOCOCCUS AUREUS INFECTIONS

  2002cited by this paper
• Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.

  2001cited by this paper
• Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.

  2001cited by this paper
• Primer3 on the WWW for general users and for biologist programmers.

  2000cited by this paper
• Molecular Analyses of Possible Mechanisms Coding for Low-Level Mupirocin Resistance in Clinical Staphylococcus aureus Isolates

  2000cited by this paper
• Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy.

  1999cited by this paper
• Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin.

  1999cited by this paper
• Prevalence of a Putative Efflux Mechanism among Fluoroquinolone-Resistant Clinical Isolates ofStreptococcus pneumoniae

  1998cited by this paper
• The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice.

  1998influential reference
• A comparative study with two administration schedules of leucovorin and 5-fluorouracil in advanced colorectal cancer.

  1995cited by this paper
• Update on mupirocin resistance.

  1995cited by this paper
• Update on mupirocin resistance.

  1995cited by this paper
• Active efflux mechanisms for antimicrobial resistance

  1992cited by this paper
• [Antimicrobial combinations].

  1972cited by this paper

• Synergistic activity of mupirocin in combination with protocatechuic acid ethyl ester against mupirocin-resistant MRSA

  2026cites this paper
• Recent advances in antibacterial phytochemicals derived from edible and medicinal plants and application in food industry.

  2026cites this paper
• A review on the comparative efficacy of species as natural preservatives

  2025cites this paper
• Diclofenac-mediated resensitisation of Methicillin-Resistant Staphylococcus aureus (MRSA) to ciprofloxacin via NorA efflux pump inhibition

  2025cites this paper
• Piper nigrum as a Source of Antimicrobial Agents: Bioactive Constituents, Mechanistic Insights, and Synthetic Derivatives for Antibacterial Applications

  2025cites this paper
• A review of antibiotic resistance generation and control in wastewater and solid waste system

  2025cites this paper
• 5-(3, 4-methylenedioxyphenyl)-4-ethyl-2E, 4E-pentadienoic acid piperidide as MdeA efflux pump inhibitor of Staphylococcus aureus.

  2025cites this paper
• Divergent risk gene profiles in smallholder and large-scale paddy farms.

  2025cites this paper
• Mupirocin-Piperine Microemulsion Hydrogels Accelerate Healing of Infected Wounds through Deep Penetration and Biofilm Disruption.

  2025cites this paper
• Therapeutic Potential of Piper longum: A Review of Piperine and Piperlongumine in Human Health

  2025cites this paper
• Phytochemical-Loaded Thermo-responsive Liposome for Synergistic Treatment of Methicillin-Resistant Staphylococcus aureus Infection

  2025cites this paper
• Navigating Antibiotic Resistance in Gram-Negative Bacteria: Current Challenges and Emerging Therapeutic Strategies.

  2025cites this paper
• Plant-derived efflux pump inhibitors potentiate Chlorin e6-based antimicrobial photodynamic therapy against Bacillus cereus and Escherichia coli.

  2025cites this paper
• Piperine-loaded mesoporous silica nanoparticles as a promising strategy for targeting Echinococcus granulosus protoscoleces

  2025cites this paper
• Bacterial Efflux Pump Inhibitors Reduce Antibiotic Resistance

  2024cites this paper
• Understanding the synergistic sensitization of natural products and antibiotics: An effective strategy to combat MRSA.

  2024cites this paper
• In Silico and In Vitro Screening of Selected Antimicrobial Compounds for Inhibiting Drug Efflux Pumps to Combat Threatening MRSA

  2024cites this paper
• Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to Acinetobacter baumannii

  2024cites this paper
• Antibacterial and immunological properties of piperine evidenced by preclinical studies: a systematic review.

  2023cites this paper
• Significant Advancement in Various Synthetic Strategies and Pharmacotherapy of Piperine Derivatives: A Review.

  2023cites this paper
• Progress in the Prevalence, Classification and Drug Resistance Mechanisms of Methicillin-Resistant Staphylococcus aureus

  2023cites this paper
• The Major Facilitator Superfamily and Antimicrobial Resistance Efflux Pumps of the ESKAPEE Pathogen Staphylococcus aureus

  2023cites this paper
• Bioenhancers from mother nature: an overview

  2023cites this paper
• Chinese herbal compound for multidrug-resistant or extensively drug-resistant bacterial pneumonia: a meta-analysis and trial sequential analysis with association rule mining to identify core herb combinations

  2023cites this paper
• In vitro and in vivo efficacy of Larrea divaricata extract for the management of Phytophthora palmivora in olive trees

  2023cites this paper
• Exploring the Antibacterial Potential of Semisynthetic Phytocannabinoid: Tetrahydrocannabidiol (THCBD) as a Potential Antibacterial Agent against Sensitive and Resistant Strains of Staphylococcus aureus.

  2023cites this paper
• Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in Acinetobacter baumannii ATCC 19606

  2022cites this paper
• Plant Secondary Metabolites for Tackling Antimicrobial Resistance: A Pharmacological Perspective

  2022cites this paper
• NorA, Tet(K), MepA, and MsrA efflux pumps in Staphylococcus aureus, their inhibitors and 1,8-naphthyridine sulfonamides.

  2022cites this paper
• Impeding efflux-mediated resistance in Staphylococcus aureus

  2022cites this paper
• Synthesis and Characterization of Piperine Amide analogues: Their In-silico and invitro analysis as Potential antibacterial agents

  2022cites this paper
• Therapeutic spectrum of piperine for clinical practice: a scoping review

  2022cites this paper
• Bioactive Component of Black Pepper‐Piperine: Structure‐Activity Relationship and Its Broad‐Spectrum Activity—An Overview

  2021cites this paper
• Synthesis, in vitro and in silico anti‐bacterial analysis of piperine and piperic ester analogues

  2021cites this paper
• Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition

  2021cites this paper
• The Protective Action of Piperlongumine Against Mycobacterial Pulmonary Tuberculosis in Its Mitigation of Inflammation and Macrophage Infiltration in Male BALB/c Mice

  2021cites this paper
• Identified Seaweed Compound Diphenylmethane Serves as an Efflux Pump Inhibitor in Drug-Resistant Escherichia coli

  2021influential citation
• Focused review on dual inhibition of quorum sensing and efflux pumps: A potential way to combat multi drug resistant Staphylococcus aureus infections.

  2021cites this paper
• Antibacterial potential of selected phytomolecules: An experimental study

  2021cites this paper
• Naturally-Occurring Alkaloids of Plant Origin as Potential Antimicrobials against Antibiotic-Resistant Infections

  2020cites this paper
• Characteristics, Biological Properties and Analytical Methods of Piperine: A Review

  2020cites this paper
• DRYING EFFECTS ON THE BIOACTIVITY OF PIPER NIGRUM LINN BERRIES

  2020cites this paper
• Piperine: A review of its biological effects

  2020cites this paper
• Antibacterial Activity of Constituents from Piper retrofractum Vahl. and Piper arborescens Roxb.

  2020cites this paper
• Novel Opportunity to Reverse Antibiotic Resistance: To Explore Traditional Chinese Medicine With Potential Activity Against Antibiotics-Resistance Bacteria

  2020cites this paper
• AN UPDATE ON BIO-POTENTIATION OF DRUGS USING NATURAL OPTIONS

  2020cites this paper
• Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

  2019cites this paper
• Brown and Red Seaweeds Serve as Potential Efflux Pump Inhibitors for Drug-Resistant Escherichia coli

  2019cites this paper
• The larvicidal activity of natural inspired piperine-based dienehydrazides against Culex pipiens.

  2019cites this paper
• Role of piperine in CNS diseases: pharmacodynamics, pharmacokinetics and drug interactions

  2019cites this paper
• Synthesis and Antimicrobial Activity of Piperine Analogues Containing 1,2,4-Triazole Ring

  2019cites this paper
• Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials

  2019cites this paper
• Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo.

  2018cites this paper
• Epidihydropinidine, the main piperidine alkaloid compound of Norway spruce (Picea abies) shows antibacterial and anti-Candida activity

  2018cites this paper
• Synthesis and in vitro and in silico antimicrobial studies of novel piperine–pyridine analogs

  2018cites this paper
• Bioprospecting of Endophytic Fungi for Bioactive Compounds

  2018cites this paper
• Modulation of antimicrobial efflux pumps of the major facilitator superfamily in Staphylococcus aureus

  2018cites this paper
• Alkaloid-Rich Crude Extracts, Fractions and Piperamide Alkaloids of Piper guineense Possess Promising Antibacterial Effects

  2018cites this paper
• Functional Roles of Highly Conserved Amino Acid Sequence Motifs A and C in Solute Transporters of the Major Facilitator Superfamily

  2017cites this paper
• Reversing antibacterial resistance of Staphylococcus aureus: the use of phytochemicals as antibiotic-adjuvants and resistance-modifying agents towards more effective therapies

  2017cites this paper
• Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.

  2017cites this paper
• Drug Resistance in Bacteria , Fungi , Malaria , and Cancer

  2017cites this paper
• Epidihydropinidine, the main piperidine alkaloid compound of Norway spruce (Picea abies) shows promising antibacterial and anti-Candida activity.

  2017cites this paper
• Biochanin A partially restores the activity of ofloxacin and ciprofloxacin against topoisomerase IV mutation‐associated fluoroquinolone‐resistant Ureaplasma species

  2017cites this paper
• Transcriptional Regulator TetR21 Controls the Expression of the Staphylococcus aureus LmrS Efflux Pump

  2017cites this paper
• Piperine Plays an Anti-Inflammatory Role in Staphylococcus aureus Endometritis by Inhibiting Activation of NF-κB and MAPK Pathways in Mice

  2016cites this paper
• Efflux Pump Mediated Second-Line Tuberculosis Drug Resistance

  2016cites this paper
• Antimicrobial Drug Efflux Pump Inhibitors

  2016cites this paper
• Holarrhena antidysenterica Extract and Its Steroidal Alkaloid, Conessine, as Resistance-Modifying Agents Against Extensively Drug-Resistant Acinetobacter baumannii

  2016cites this paper
• Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus.

  2016cites this paper
• Multidrug Efflux Pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus Bacterial Food Pathogens

  2015cites this paper
• Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus

  2015cites this paper
• Piperine: bioactivities and structural modifications.

  2015cites this paper
• Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.

  2015cites this paper
• Discovery of Some Piperine-Based Phenylsulfonylhydrazone Derivatives as Potent Botanically Narcotic Agents

  2015cites this paper
• Plant derived inhibitors of bacterial efflux pumps: an update

  2015cites this paper
• Evaluation of cell membrane integrity as a potential antimicrobial target for plant products

  2014cites this paper
• Regulation of Expression of abcA and Its Response to Environmental Conditions

  2014cites this paper
• Effect of Lippia origanoides H.B.K. essential oil in the resistance to aminoglycosides in methicillin resistant Staphylococcus aureus

  2014cites this paper
• Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: reversing the resistance against frontline antibacterial drugs

  2014cites this paper
• , Zoe Response to Environmental Conditions and Its abcA Regulation of Expression of

  2014cites this paper
• Evaluation of activity of recombinant lysostaphin against isolates of meticillin-resistant Staphylococcus aureus from Indian hospitals.

  2014cites this paper
• Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics.

  2013cites this paper
• Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily

  2013influential citation
• Inhibition of drug efflux pumps in Staphylococcus aureus: current status for potentiating existing

  2013cites this paper
• Natural-product-based insecticidal agents 14. Semisynthesis and insecticidal activity of new piperine-based hydrazone derivatives against Mythimna separata Walker in vivo.

  2013cites this paper
• Biological Evaluation of Some Antimicrobial Nano‐Materials

  2013cites this paper
• Plants as sources of new antimicrobials and resistance-modifying agents.

  2012cites this paper
• Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections

  2012cites this paper
• Send Orders of Reprints at Reprints@benthamscience.net Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation

  year unknowncites this paper